Protocol of Whey Protein Isolate-Based Microgel Targeted Delivery in Mouse Kidney

Oksana A Mayorova1, Mariia S Saveleva1, Daria A Terentyeva2

  • 1Science Medical Center, Saratov State University, Saratov, Russia.

Bio-Protocol
|July 8, 2025
PubMed

Insights

Researchers developed novel whey protein isolate microgels for targeted kidney drug delivery, showing significant accumulation in kidneys and liver after intravenous injection in mice. This method aims to reduce systemic side effects and improve treatment efficacy for chronic kidney disease.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) cases are rising, with delayed treatment leading to kidney failure.
  • Current systemic therapies for kidney disease can harm other organs.
  • Targeted drug delivery to kidneys is crucial to minimize side effects and improve efficacy.

Purpose of the Study:

  • To present a protocol for synthesizing emulsion microgels stabilized with whey protein isolate (WPI) for targeted kidney drug delivery.
  • To evaluate the stability and biodistribution of these novel microgels.
  • To assess the biocompatibility and potential therapeutic efficacy of the microgel system.

Main Methods:

  • Synthesis of fluorescently labeled emulsion microgels using mucoadhesive WPI.
  • Stability studies of microgels using optical microscopy to analyze droplet size over time.
  • Intravenous administration of microgel suspension into mice via tail vein.
  • Confocal microscopy for sample preparation and visualization of microgel biodistribution.

Main Results:

  • Emulsion microgels demonstrated time-dependent degradation, starting after 72 hours.
  • Significant selective accumulation of microgels was observed in the liver and kidneys within 5 days post-injection.
  • The protocol allows for the replication of microgel synthesis and evaluation of their in vivo behavior.

Conclusions:

  • Whey protein isolate-based emulsion microgels are a promising system for targeted drug delivery to the kidneys.
  • The developed protocol enables the synthesis and evaluation of these microgels for potential therapeutic applications in CKD.
  • This approach offers a strategy to reduce drug toxicity and improve treatment outcomes for kidney diseases.

Related Concept Videos